Tenet Healthcare (NYSE:THC) Stock Price Target Cut by Guggenheim

Tenet Healthcare (NYSE:THC) had its price objective cut by Guggenheim from $307.00 to $306.00 in a research report issued on Friday, Benzinga reports. The firm currently has a “buy” rating on the stock. Guggenheim‘s target price indicates a potential upside of 13.47% from the stock’s previous close.

Several other brokerages have also recently commented on THC. Wells Fargo & Company raised their target price on Tenet Healthcare from $231.00 to $281.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. Leerink Partners reaffirmed an “outperform” rating and set a $309.00 price target on shares of Tenet Healthcare in a report on Friday, September 18th. Morgan Stanley boosted their price objective on Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a research note on Monday, July 27th. Stephens restated an “overweight” rating and issued a $285.00 target price on shares of Tenet Healthcare in a research note on Monday, July 27th. Finally, UBS Group lifted their price target on Tenet Healthcare from $288.00 to $308.00 and gave the company a “buy” rating in a report on Monday, July 27th. Eighteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, Tenet Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $280.16.

Tenet Healthcare Stock Performance

Shares of THC opened at $269.67 on Friday. The company’s fifty day moving average is $264.85 and its 200-day moving average is $219.97. The company has a quick ratio of 1.35, a current ratio of 1.41 and a debt-to-equity ratio of 2.00. Tenet Healthcare has a 12 month low of $157.58 and a 12 month high of $283.05. The firm has a market cap of $21.71 billion, a price-to-earnings ratio of 10.37, a price-to-earnings-growth ratio of 1.02 and a beta of 1.20.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings data on Thursday, October 29th. The company reported $6.64 earnings per share for the quarter, topping analysts’ consensus estimates of $4.68 by $1.96. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The business had revenue of $6.28 billion during the quarter, compared to analysts’ expectations of $5.49 billion. During the same period in the previous year, the company earned $3.70 earnings per share. Tenet Healthcare’s revenue for the quarter was up 6.5% on a year-over-year basis. Equities analysts expect that Tenet Healthcare will post 21.04 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, Director Nadja West sold 1,152 shares of the firm’s stock in a transaction dated Wednesday, September 2nd. The stock was sold at an average price of $258.80, for a total value of $298,137.60. Following the completion of the transaction, the director owned 23,653 shares in the company, valued at $6,121,396.40. This trade represents a 4.64% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Richard Mark sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, September 10th. The shares were sold at an average price of $263.42, for a total value of $2,634,200.00. Following the completion of the sale, the director directly owned 25,121 shares of the company’s stock, valued at approximately $6,617,373.82. The trade was a 28.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 106,484 shares of company stock valued at $28,898,063 over the last 90 days. 0.97% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Tenet Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of THC. Manning & Napier Advisors LLC bought a new stake in shares of Tenet Healthcare in the 2nd quarter valued at $168,761,000. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Tenet Healthcare by 57.4% in the first quarter. Arrowstreet Capital Limited Partnership now owns 671,700 shares of the company’s stock valued at $126,757,000 after purchasing an additional 244,901 shares in the last quarter. Bank of New York Mellon Corp bought a new position in Tenet Healthcare during the 2nd quarter valued at $106,342,000. Empowered Funds LLC raised its holdings in shares of Tenet Healthcare by 22.1% in the first quarter. Empowered Funds LLC now owns 284,753 shares of the company’s stock valued at $53,736,000 after purchasing an additional 51,549 shares during the last quarter. Finally, Hsbc Holdings PLC lifted its position in shares of Tenet Healthcare by 3,478.7% during the fourth quarter. Hsbc Holdings PLC now owns 266,400 shares of the company’s stock valued at $53,269,000 after purchasing an additional 258,956 shares in the last quarter. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare News Roundup

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet reported quarterly adjusted earnings of $6.64 per share, well above the roughly $4.60–$4.68 analyst consensus and up from $3.70 in the year-ago quarter. Revenue reached $6.28 billion, exceeding the $5.49 billion estimate and increasing 6.5% year over year. Tenet Healthcare Surpasses Q3 Earnings and Revenue Estimates
• Positive Sentiment: Strong hospital operations, combined with cost discipline, drove an approximately 79.5% year-over-year increase in earnings and supported management’s decision to raise its 2026 earnings-per-share and EBITDA guidance. Higher guidance generally improves expectations for future cash flow and valuation. THC Q3 Earnings Beat on Hospital Strength
• Positive Sentiment: The company characterized the quarter as strong across its operations and raised its broader 2026 financial outlook, reinforcing the view that recent performance is not limited to a single revenue increase. Tenet Healthcare Sails Past Q3 Estimates
• Positive Sentiment: Before the earnings release, Tenet was also being highlighted as a value stock, with a relatively low reported P/E ratio compared with its earnings growth profile. Why Tenet Healthcare Is a Strong Value Stock

Tenet Healthcare Company Profile

Tenet Healthcare Corp. (NYSE: THC) is a diversified healthcare services company headquartered in Dallas, Texas. Through its hospital operations and outpatient platforms, the company provides a range of medical services to patients across the United States.

Tenet operates acute care and specialty hospitals, ambulatory surgery centers, imaging facilities and other outpatient care sites. Its United Surgical Partners International subsidiary is a major provider of ambulatory surgery services and partners with physicians and health systems.